Skip to content
lifestyle.getpetsavvy.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Kailera Therapeutics, Inc.
Kailera Therapeutics Appoints Nur Nicholson as Chief Technology Officer
August 11, 2026
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
July 7, 2026
Kailera Therapeutics Appoints Kathleen Tregoning as Chief Corporate Affairs Officer
June 29, 2026
Hengrui Pharma and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 86th Scientific Sessions
May 13, 2026
Kailera Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
April 20, 2026
Kailera Therapeutics Announces Pricing of Initial Public Offering
April 16, 2026